Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI
MK Andersen, TS Høiem, BSR Claes, B Balluff… - Cancer & …, 2021 - Springer
Background Prostate cancer tissues are inherently heterogeneous, which presents a
challenge for metabolic profiling using traditional bulk analysis methods that produce an …
challenge for metabolic profiling using traditional bulk analysis methods that produce an …
A decade in prostate cancer: from NMR to metabolomics
Over the past 30 years, continuous progress in the application of nuclear magnetic
resonance (NMR) spectroscopy and magnetic resonance spectroscopic imaging (MRSI) to …
resonance (NMR) spectroscopy and magnetic resonance spectroscopic imaging (MRSI) to …
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness
GF Giskeødegård, H Bertilsson, KM Selnæs, AJ Wright… - PloS one, 2013 - journals.plos.org
Separating indolent from aggressive prostate cancer is an important clinical challenge for
identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment …
identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment …
[HTML][HTML] Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)
TL Fuss, LL Cheng - Metabolites, 2016 - mdpi.com
According to World Health Organization (WHO) estimates, cancer is responsible for more
deaths than all coronary heart disease or stroke worldwide, serving as a major public health …
deaths than all coronary heart disease or stroke worldwide, serving as a major public health …
Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma
Reactive stroma is a tissue feature commonly observed in the tumor microenvironment of
prostate cancer and has previously been associated with more aggressive tumors. The aim …
prostate cancer and has previously been associated with more aggressive tumors. The aim …
A novel non-canonical Wnt signature for prostate cancer aggressiveness
E Sandsmark, AF Hansen, KM Selnæs… - …, 2016 - pmc.ncbi.nlm.nih.gov
Activation of the Canonical Wnt pathway (CWP) has been linked to advanced and metastatic
prostate cancer, whereas the Wnt5a-induced non-canonical Wnt pathway (NCWP) has been …
prostate cancer, whereas the Wnt5a-induced non-canonical Wnt pathway (NCWP) has been …
Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics
M Austdal, LCV Thomsen, LH Tangerås, B Skei… - Placenta, 2015 - Elsevier
Introduction Preeclampsia is a heterogeneous gestational disease characterized by
maternal hypertension and proteinuria, affecting 2–7% of pregnancies. The disorder is …
maternal hypertension and proteinuria, affecting 2–7% of pregnancies. The disorder is …
Simultaneous detection of zinc and its pathway metabolites using MALDI MS imaging of prostate tissue
MK Andersen, S Krossa, TS Høiem… - Analytical …, 2020 - ACS Publications
Levels of zinc, along with its mechanistically related metabolites citrate and aspartate, are
widely reported as reduced in prostate cancer compared to healthy tissue and are therefore …
widely reported as reduced in prostate cancer compared to healthy tissue and are therefore …
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples
Purpose: Low concentrations of citrate and high concentrations of choline-containing
compounds (ChoCC) are metabolic characteristics observed by magnetic resonance …
compounds (ChoCC) are metabolic characteristics observed by magnetic resonance …
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Background: Robust biomarkers that identify prostate cancer patients with high risk of
recurrence will improve personalised cancer care. In this study, we investigated whether …
recurrence will improve personalised cancer care. In this study, we investigated whether …